Skip to content

13D/A filed by venBio Global Strategic Fund, L.P.

venBio Global Strategic Fund, L.P. and 6 other reporting persons reported 12,927,442 ALXO shares, 9.99% of the class, as of 2026-10-14, in a 13D/A accepted by EDGAR 2026-10-17 01:21:15 UTC.

Accession
0000905148-26-004485
Filer
CIK 1504130
Filed
2026-10-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
12,927,442
Percent of class
9.99%
Event date
2026-10-14

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group venBio Global Strategic Fund, L.P..

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
venBio Global Strategic Fund, L.P.PN04,307,03404,307,0344,307,0343.3%
venBio Global Strategic Fund II L.P.PN08,453,03808,453,0388,453,0386.5%
venBio Global Strategic GP, L.P.PN04,307,03404,307,0344,307,0343.3%
venBio Global Strategic GP II, L.P.PN08,453,03808,453,0388,453,0386.5%
venBio Global Strategic GP, Ltd.CO04,307,03404,307,0344,307,0343.3%
venBio Global Strategic GP II, Ltd.CO08,453,03808,453,0388,453,0386.5%
GOODMAN COREY SIN,HC012,927,442012,927,44212,927,4429.99%